We have used expression of a kinase dead mutant of PKCa (PKCaKD) to explore the role of this isoform in salivary epithelial cell apoptosis. Expression of PKCaKD by adenovirus-mediated transduction results in a dose-dependent induction of apoptosis in salivary epithelial cells as measured by the accumulation of sub-G1 DNA, activation of caspase-3, and cleavage of PKCd and PKCf, known caspase substrates. Induction of apoptosis is accompanied by ninefold activation of c-Jun-N-terminal kinase, and an approximately two to three-fold increase in activated mitogenactivated protein kinase (MAPK) as well as total MAPK protein. Previous studies from our laboratory have shown that PKCd activity is essential for the apoptotic response of salivary epithelial cells to a variety of cell toxins. To explore the contribution of PKCd to PKCaKD-induced apoptosis, salivary epithelial cells were cotransduced with PKCaKD and PKCdKD expression vectors. Inhibition of endogenous PKCd blocked the ability of PKCaKD to induce apoptosis as indicated by cell morphology, DNA fragmentation, and caspase-3 activation, indicating that PKCd activity is required for the apoptotic program induced under conditions where PKCa is inhibited. These findings indicate that PKCa functions as a survival factor in salivary epithelial cells, while PKCd functions to regulate entry into the apoptotic pathway.
Introduction
Apoptosis is important for the clearance of damaged or variant cells, and alterations in apoptosis may contribute to the pathogenesis of cancer and other disorders. [1] [2] [3] [4] Key regulators of the apoptotic pathway include pro-and antiapoptotic members of the Bcl-2 family, caspase proteases, which cleave cellular proteins, and the family of IAP proteins, which regulate the activity of activated caspases. [5] [6] [7] Serine/threonine protein kinases are also known to regulate apoptosis, including the phosphoinositide 3-kinase/AKT pathway, 8, 9 members of the mitogen-activated protein kinase family (MAPKs), [10] [11] [12] and the protein kinase C (PKC) pathway. [13] [14] [15] [16] [17] The PKC family consists of 11 isoforms, with individual isoforms exhibiting varying substrate specificity, as well as differences in their subcellular localization and response to specific stimuli. 18, 19 This argues that specific isoforms of PKC play unique roles in transducing cell signals. In support of this, both pro-and antiapoptotic isoforms of PKC have been described. For example, PKCd is required for apoptosis induced by genotoxins, 16 phorbol ester, 20 and Fas ligand, 21 while PKCl and PKCz protect against apoptosis. 22, 23 Accumulated evidence suggests an antiapoptotic/proproliferative function for PKCa. PKCa is overexpressed in a variety of tumor cells and has been suggested to play a role in the proliferation of gliomas, 24 liver, 25 and endometrial tumors. 26 Depletion of PKCa induces apoptosis in glioblastoma multiforme cells 27 and in COS-7 cells. 17 Two studies have explored the molecular mechanism by which PKCa protects against apoptosis. Ruvolo et al. 28 have shown that PKCa can phosphorylate Bcl-2 in vitro, and that overexpression of PKCa results in increased Bcl-2 phosphorylation and suppression of apoptosis in human pre-B REH cells. Li et al. 29 demonstrate that in 32D cells, PKCa overexpression stimulates the prosurvival protein kinase, AKT, and suppresses apoptosis following growth factor withdrawal.
Our studies have focused on understanding the contribution of specific isoforms of PKC to apoptosis in salivary epithelial cells. We have previously shown that activation of PKC by phorbol ester is sufficient to induce an apoptotic program in parotid salivary epithelial cells 15 and that PKCd is essential for genotoxin-induced cell death in these cells. 13, 16 Here, we demonstrate that inhibition of endogenous PKCa induces an apoptotic program in salivary epithelial cells. As we have previously reported for other apoptotic stimuli, induction of apoptosis under these conditions requires PKCd activity, suggesting that in salivary epithelial cells PKCd may function to regulate entry into the apoptotic pathway.
Results

Inhibition of endogenous PKCa activity induces apoptosis
We have previously reported that both the expression and the specific activity of protein kinase C-a (PKCa) is increased in parotid C5 cells induced to undergo apoptosis by treatment with etoposide. 16 In the present studies, we have used an inhibitory form of PKCa to explore the function of endogenous PKCa in the apoptotic pathway. Parotid C5 cells were transduced with increasing amounts of an adenoviral vector, which expresses a kinase inhibitory mutant of PKCa (PKCaKD), or with the control adenovirus, AdlacZ. Experiments were matched for relative levels of expression of PKCaKD, as viral infectivity varied somewhat between experiments. As shown in Figure 1 , compared to nontransduced cells (panel 1), parotid C5 cells that express PKCaKD (panels 2-5) are rounded up and detached from the monolayer, characteristic of cells undergoing apoptosis. In contrast, these changes are not seen in cells that express the control adenovirus, AdLacZ (panel 6). Appearance of the apoptotic morphology is evident at 18-24 h after transduction, and maximal by 42 h after transduction, while maximal expression of PKCaKD is observed at 12-18 h and remains stable throughout the course of apoptosis (data not shown). To determine if the morphologic changes in PKCaKDexpressing cells are associated with the accumulation of fragmented DNA, transduced parotid C5 cells were stained with propidium iodide, and the percent sub-G1 DNA was determined by FACS analysis. As shown in Figure 2a , while there is little detectable sub-G1 DNA in untreated cells, inhibition of endogenous PKCa results in a dramatic increase in sub-G1 DNA which increases in a dose-dependent manner with the amount of PKCaKD expressed. Figure 2b shows quantification of sub-G1 DNA in a similar experiment. As seen here, expression of PKCaKD, but not the control adenovirus, AdlacZ, resulted in a dose-dependent accumulation of sub-G1 DNA. At the highest level of PKCaKD expression, nearly 50% of the cellular DNA was in the sub-G1 peak, a value similar to that observed in parotid C5 cells treated with 50 mM etoposide for 18 h. As shown in Figure 6b , expression of PKCaKD in parotid C5 cells likewise resulted in a dose-dependent induction of caspase-3 activity. These data indicate that inhibition of endogenous PKCa induces an apoptotic program in parotid C5 cells.
Activation of specific signal transduction pathways is well documented in cells induced to undergo apoptosis. In particular, members of the MAPK family are activated in response to stimulation with mitogenic or apoptotic agents. In some, but not all, cells, activation of the c-Jun-N-terminal kinase (JNK) pathway has been shown to be required for the apoptotic response to genotoxins and other agents. We have previously demonstrated activation of the JNK pathway, and inactivation of the MAPK pathway in parotid C5 cells induced to undergo apoptosis with etoposide 16 and phorbol ester. 15 Furthermore, inhibition of PKCd activity blocks activation of JNK and inactivation of ERK in etoposide-treated cells, linking PKC to the regulation of these pathways. 16 To determine if JNK activity is altered in parotid C5 cells induced to undergo apoptosis by expression of PKCaKD, JNK activity was assayed in parotid C5 cells transduced with increasing amounts of PKCaKD. As shown in Figure 3a , transduction with increasing amounts of PKCaDN resulted in increased PKCa protein expression. When JNK activity was assayed in the same experiment, an increase in JNK activity was observed that correlated with increased expression of PKCaKD ( Figure 3b ). As seen here, JNK is activated up to nine-fold in cells transduced with PKCaKD for 24 h. Analysis of the time course of JNK activation demonstrates an increase in JNK activity by 12 h after transduction and maximal activation by 18-24 h (data not shown). No increase in JNK activity is seen in nontransduced cells, or in cells transduced with the AdLacZ control virus. Since an increase in JNK activity could be explained by increased JNK protein expression, we Inhibition of ERK activity and the reciprocal activation of JNK has been shown to correlate with the initiation of apoptosis in calphostin C-induced cell death in glioma cells, 30 growth factor withdrawn PC-12 cells, 31 Fas-induced Jurkat cells, 12 and UV-irradiated fibroblasts. 23 To determine if ERK activity is altered in parotid C5 cells transduced with PKCaKD, active ERK1 and ERK2 were assayed using an antiactive ERK antibody that specifically recognizes the phosphorylated (active) forms of these kinases. As shown in Figure 4 , expression of PKCaKD (top), but not AdLacZ, increased the abundance of phosphorylated ERK1 and ERK2 (middle), indicating an increase in the active forms of these kinases. When these blots were reprobed with an anti-ERK antibody that recognizes total ERK, an increase in both ERK 1 and ERK2 protein abundance was observed (bottom), indicating that PKCaKD also increases ERK protein expression. These studies suggest that, in contrast to parotid C5 cells induced to undergo apoptosis with genotoxins, 16 the JNK and ERK pathways are not inversely regulated when apoptosis is induced by inhibition of endogenous PKCa.
The activation of caspase-3 and cleavage of cellular proteins is a hallmark of apoptosis induced by most stimuli. 32, 33 Among the numerous caspase-3 substrates described in apoptotic cells are the PKC isoforms, PKCd , 34 and PKCz . 35 Caspase cleavage of PKCd results in the generation of a constitutively active catalytic fragment that is sufficient to induce apoptosis when expressed in a variety of cell types. Caspase cleavage of PKCz likewise results in the generation of a fragment with catalytic activity, 35 although the function of this fragment in apoptotic cells has not been addressed. To determine if these PKC isoforms are cleaved in parotid C5 cells undergoing apoptosis in response to inhibition of endogenous PKCa, PKCd and PKCz protein expression was analyzed by immunoblot. As shown in Figure 5 , increased expression of PKCaKD (top) results in cleavage of endogenous PKCd into a 40 kDa fragment identical to that seen in etoposide-treated cells (middle). Likewise, PKCz is also cleaved into two fragments in cells expressing PKCaKD (bottom), which appear to be identical in molecular weight to the caspase cleavage fragments produced in response to etoposide.
Apoptosis induced by the inhibition of endogenous PKCa requires PKCd
PKCd has been implicated as an intermediate in apoptosis induced by a variety of agents with distinct mechanisms of action. These include phorbol ester, 14, 20 Fas/CD95, 21 and etoposide. 16 To ask if apoptosis induced by inhibition of PKCa requires PKCd activity, parotid C5 cells were transduced with PKCaKD or PKCdKD alone, or cotransduced with both adenoviruses. As shown in Figure 6a , transduction of PKCdKD together with PKCaKD (panel 1) greatly inhibits the ability of PKCaKD (panel 2) to induce apoptosis as assayed by changes in cell morphology. To determine if this block in apoptosis correlates with suppression of DNA fragmentation, parotid C5 cells were transduced with either virus, both viruses, or the control virus, AdlacZ, for 42 h and the percent of sub-G1 DNA was assayed. As shown in Figure 6b , coexpression of PKCdKD suppresses PKCaKD-induced 
DNA fragmentation by about 40%. To determine if PKCd is required for PKCaKD-induced caspase-3 activity, caspase-3 activity was assayed in cells transduced with either virus alone or both viruses. As shown in Figure 6c , expression of PKCaKD results in a dose-dependent induction of caspase-3 activity, while no increase in caspase activity was seen in cells transduced with AdlacZ. Cotransduction with PKCdKD together with PKCaKD however greatly suppressed the induction of caspase-3 activity by PKCaKD. These data indicate that apoptosis induced by the inhibition of endogenous PKCaKD proceeds through a PKCd-dependent pathway.
Discussion
The role of PKC in apoptosis is controversial, with data supporting both pro-and antiapoptotic functions. In the current studies, we have examined the role of PKCa, a PKC isoform associated with proliferation in many cell types. 24, [36] [37] [38] [39] Our studies suggest that PKCa is essential for the survival of salivary epithelial cells, and that in the absence of PKCa activity, apoptosis is initiated. Apoptosis can be inhibited by expression of an inhibitory form of PKCd, indicating that apoptosis induced under these conditions requires PKCd activity. This is in agreement with previous studies from our laboratory that have demonstrated an essential role for PKCd in apoptosis induced by a wide variety of agents. 13, 16 Thus, PKCa and PKCd appear to have reciprocal functions in salivary epithelial cells, with PKCa functioning as a survival factor, while PKCd functions to regulate entry into the apoptotic pathway. Our current studies indicate that inhibition of PKCa by expression of a kinase negative mutant is sufficient to induce apoptosis, suggesting that PKCa functions to suppress apoptosis in parotid C5 cells. We have previously reported that the expression and activity of both PKCa and PKCb1 increase following treatment of parotid C5 cells with etoposide. 16 An increase in PKCa protein abundance in etoposidetreated cells can also be shown in Figure 5 . Shao et al. 40 also show that PKCa is activated following induction of apoptosis by genotoxic agents in HL-60 myeloid cells. In the light of our current findings, this increase in PKCa in response to genotoxins may represent a survival signal. Previous studies from our laboratory have shown that transfection of parotid C5 cells with a plasmid that expresses a kinase dead mutant of PKCa did not induce apoptosis. 15 The apparent discrepancy between these studies and our current observation may be owing to the higher level of expression achieved by adenoviral-facilitated expression of PKCaKD (Matassa and Reyland, unpublished data) . Importantly, our current findings are in line with studies from other investigators including Whelan and Parker, 17 who showed that loss of PKC function induced apoptosis in COS-1 and U937 cells. In addition, specific targeting of PKCa by antisense oligonucleotides or ribozymes blocks the growth of gliomas and increases apoptosis, 38, 39 and inhibits the growth of lymphoma cells. 41 Several studies suggest that the prosurvival function of PKCa may result from direct regulation of specific components of the apoptotic machinery. Ruvolo et al. 25 show that activation of mitochondrial PKCa results in phosphorylation of the antiapoptotic protein, Bcl-2. In these studies, overexpression of PKCa correlated with increased resistance to etoposideinduced apoptosis and increased phosphorylation of Bcl-2. 28 Li et al. 29 report that overexpression of PKCa activates the prosurvival function of serine-threonine kinase, Akt, and suppresses apoptosis induced by growth factor withdrawal.
Activation of the c-Jun terminal kinases (JNKs) has been shown to promote either apoptosis or survival signaling depending on the cellular context. 42 In particular, the sustained or persistent activation of JNK has been associated with apoptosis in a number of cell types. [43] [44] [45] We have previously reported that in salivary epithelial cells, apoptosis induced by etoposide or TPA correlates with sustained activation of JNK. 15, 46 Treatment of parotid C5 cells with etoposide resulted in the activation of JNK in 4-6 h, which was maintained throughout the time course of apoptosis, 46 while treatment of parotid cells with TPA resulted in a biphasic activation of JNKs with the later phase commencing by 4 h. 15 In the current studies, we extend these observations to show that sustained activation of JNK also occurs in parotid C5 cells induced to undergo apoptosis by inhibition of PKCa. Activation of JNK occurred as early as 12 h after transduction and was maximal at 18-24 h (data not shown). These studies suggest that activation of JNK is an early event in the response of salivary epithelial cells to apoptotic stimuli. This is supported by studies in JNK null MEF cells in which a marked deficiency in mitochondrial-dependent apoptosis is observed including a block in cytochrome c release, an early event in the apoptotic pathway. 47 In contrast to the JNK pathway, most studies indicate that activation of extracellular regulated kinases (ERKs) protects against apoptosis, 31, 48, 49 while more limited data suggest a role for ERK activation in promoting apoptosis.
50-52 Indeed, we have previously shown that ERK is inactivated in parotid C5 cells induced to undergo apoptosis by treatment with etoposide 46 or TPA. 15 However, the data presented in the current manuscript show that apoptosis associated with PKCa inhibition correlates with an increase in the expression of ERK1 and ERK2 protein as well as an increase in the abundance of the phosphorylated or activated forms of these kinases. While this may indicate that PKCa normally functions to suppress ERK expression and activity in parotid C5 cells, this seems unlikely given a variety of reports which demonstrate that PKCa, as well as other PKC isoforms, activate ERK. [53] [54] [55] A more likely explanation is that activation of ERK1/ 2 and its increased expression is a component of the apoptotic pathway induced by the loss of PKCa activity, and does not reflect loss of a normal physiologic function of PKCa. Interestingly, PKCd has also been shown to be a positive regulator of ERK, 50, 55, 56 and expression of a dominant negative PKCd construct blocked the activation of ERK in cells induced to undergo apoptosis by treatment with UV light. 50 We show that PKCd is activated during apoptosis in parotid C5 cells which express PKCaKD ( Figure 5 ) and that PKCaKD-induced apoptosis requires PKCd activity ( Figure 6) ; thus, activation of PKCd may account for the activation of ERK under these conditions.
Our current studies clearly define distinct and opposing functions for PKCa and PKCd in salivary epithelial cells. Studies by Mandil et al. 24 suggest that these two isoforms play similar opposing roles in glioma cells. Here, we link these isoforms in the apoptotic pathway by demonstrating that apoptosis induced by PKCa inhibition is dependent upon PKCd activity. Similar to these other apoptotic agents, inhibition of PKCd suppresses caspase activation as well as DNA fragmentation, indicating that PKCd functions at an early point in the apoptotic pathway. However, expression of PKCd KD does not totally block PKCaKD-induced apoptosis, suggesting that apoptosis induced by inhibition of PKCa may also involve an additional pathway that is independent of PKCd. The requirement of PKCd for apoptosis in response to diverse signals, including inhibition of endogenous PKCa, suggests that PKCd may function to regulate entry into the apoptotic pathway in epithelial and perhaps other cell types.
Materials and Methods
Cells and cell culture
The isolation of the salivary parotid C5 cell line has been described elsewhere. 57 Cells were cultured on Primaria 60 mm culture dishes (Falcon Plastics, Franklin Lakes, NJ, USA) in a 1 : 1 mixture of Dulbeccos modified Eagle media/Nutrient mixture F-12 (DMEM/F12) supplemented with 2.5% fetal calf serum, 5 mg/ml transferrin, 1.1 mM hydrocortisone, 0.1 mM retinoic acid, 2.0 nM T3, 5 mg/ml insulin, 80 ng/ml epidermal growth factor (Collaborative Biomedical Products, Bedford, MA, USA), 5 mM Lglutamine, 50 mg/ml gentamicin sulfate, and a trace element mixture (Biofluids, Rockville, MD, USA). Tissue culture reagents were obtained from GIBCO/BRL (Gaithersburg, MD, USA) unless otherwise indicated. Etoposide was purchased from Sigma-Aldrich.
Construction of adenoviral vectors and transduction of parotid C5 cells
Generation of the wild-type and kinase dead recombinant rat PKCd adenoviruses has been previously described. 58 The kinase dead mutant (K376R) has been shown to function as an isoform-specific dominant inhibitory kinase. 59 To make the kinase dead mutant of PKCa (PKCaKD), mutagenesis was performed using a primer that targeted the conserved lysine in the ATP-binding domain (TACGCCATCAGGATCCTGAAG) of the mouse PKCa cDNA. The resulting mutant (K368R) cDNA was subcloned into the adenoviral shuttle vector, pXCMV, and recombinant adenovirus was prepared essentially as described. 60 An adenoviral vector expressing the b-galactosidase gene (AdlacZ) was a generous gift of J Schaack, University of Colorado Health Sciences Center. 61 Adenoviruses were titered on 293 HEK cells using a focus forming assay, which detects expression of the adenoviral protein E2. 62 Subconfluent parotid C5 cells were transduced with AdlacZ or PKCaKD for 1 h at different multiplicites of transduction (MOIs) (6-100 focus forming units (ffu)/cell) in DMEM/F12 supplemented as described above but without the addition of serum. Following the transduction period, the viruscontaining media were replaced with supplemented DMEM/F12 containing 2.5% FBS and cells were incubated for an additional 42 h.
Immunoblotting
Adherent and floating cells were collected as previously described 16 and resuspended in 1 ml of JNK lysis buffer (25 mM HEPES, pH 7.5, 20 mM b-glycerophosphate, 0.1 mM sodium orthovanadate, 0.1% Triton X-100, 0.3 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, 10 mM NaF, and 4 mg/ml each aprotinin and leupeptin). The lysate was allowed to sit on ice for 30 min and then clarified by spinning at 12 500 rpm for 5 min in a refrigerated Savant SRF13 K microfuge. Protein concentration was determined using a Bradford assay kit purchased from Biorad. Cell lysates (25-50 mg) were resolved by 10% SDS-PAGE, transferred to an Immobilon membrane (Millipore), and immunoblotted with the desired antibody as described previously. 16 Enhanced chemiluminescence (ECL; Amersham) followed by autoradiography was used to detect the signal. Antibodies to JNK, actin, and PKC were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The anti-PKC antibodies recognize an epitope in the carboxy-terminal portion of the protein. For immunoblots from cells transduced with PKCdKD, the PKCa and PKCz antibodies were preabsorbed with four times excess of PKCd blocking peptide (Santa Cruz) by shaking for 1 h at room temperature. The antiactive ERK2 antibody, which cross-reacts with both phosphorylated ERK1 and ERK2, was obtained from Promega Biotechnology (Madison, WI, USA). An anti-MAP kinase antibody, which cross-reacts with both ERK1 and ERK2, was obtained from Upstate Biotechnology (Lake Placid, NY, USA).
Measurement of caspase activity
N-acetyl-Asp-Glu-Val-Asp-p-nitroaniline (Ac-DEVD-pNA) (caspase-3) cleavage was assayed as previously described. 46 
Preparation of cells for fluorescence-activated cell sorting (FACS)
The medium, containing floating cells, was removed and saved. Cells were removed from a P60 dish by the addition of 3 ml cell dispersion solution (0.25% trypsin-EDTA, 68 mM EGTA, pH 7.4, 100 mg/ml pronase) and incubation at 371C for 15 min. An equal volume of trypsin inhibitor cocktail (86 mM NaCl, 30 mM KCl, 1 mM NaH 2 PO 4 , 3 mM MgSO 4 , 0.5 mM CaCl, 15 mM glucose, 18 mM NaCO 3 , 0.5 mM adenosine, 20 mM taurine, 2 mM DL-carnitine, 0.5% bovine serum albumin, and 80 mg/ml trypsin inhibitor (Sigma)) was added and a single-cell suspension was made by pushing cells 4 Â through a 20 gauge needle, 2 Â through a 23 gauge needle, and 2 Â through a 26 gauge needle. Suspended cells were combined with the medium containing floating cells and centrifuged at 1000 Â g for 3 min. The pellet was washed once with PBS and the cells were then resuspended in the desired reagent.
Analysis of DNA content
Cells were prepared for FACS as described above and the cell pellet was resuspended in 0.5 ml of saponin-propidium iodide solution (0.3 mg/ml saponin, 25 mg/ml propidium iodide, 10 mM EDTA, and 5 mg/ml RNase). Cells were stained for 5-24 h at 41C in the dark prior to the FACS analysis.
Kinase assay for JNK activity
The GST-c-Jun (1-79) expression vector was kindly provided by Dr. Lynn Heasley (University of Colorado Health Sciences Center, Denver, CO, USA), and the fusion proteins were prepared as described. 63 JNK activation was assayed using the GST-Jun kinase assay 64 as previously described. 16 The reaction products were resolved on a 10% SDS polyacrylamide gel. The position of GST-Jun was determined by staining the gel, and the extent of GST-Jun phosphorylation was determined by autoradiography.
